Cargando…

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme

Tumor mutational burden (TMB) has recently been approved as an agnostic biomarker for immune checkpoint inhibitors. However, methods for TMB testing have not yet been standardized. The International Quality Network for Pathology (IQNPath) organized a pilot external quality assessment (EQA) scheme fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito Abate, Riziero, Cheetham, Melanie H., Fairley, Jennifer A., Pasquale, Raffaella, Sacco, Alessandra, Nicola, Wolstenholme, Deans, Zandra C., Patton, Simon J., Normanno, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931778/ https://www.ncbi.nlm.nih.gov/pubmed/36355212 http://dx.doi.org/10.1007/s00428-022-03444-y

Ejemplares similares

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey
por: Deans, Zandra C., et al.
Publicado: (2017)

Tumor mutation burden testing: a survey of the International Quality Network for Pathology (IQN Path)
por: Fenizia, Francesca, et al.
Publicado: (2021)

IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing
por: Deans, Zandra C., et al.
Publicado: (2019)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
por: Keppens, Cleo, et al.
Publicado: (2018)

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL
por: Deans, Zandra C, et al.
Publicado: (2016)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
por: Fairley, Jennifer A., et al.
Publicado: (2022)

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing
por: Patton, S, et al.
Publicado: (2014)

Challenges in bioinformatics approaches to tumor mutation burden analysis
por: Fenizia, Francesca, et al.
Publicado: (2021)

RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009–2016)
por: Richman, Susan D., et al.
Publicado: (2017)

Interpretation of EQA results and EQA-based trouble shooting
por: Kristensen, Gunn Berit Berge, et al.
Publicado: (2017)

External Quality Assessment (EQA) for Molecular Diagnostics of Zika Virus: Experiences from an International EQA Programme, 2016–2018
por: Donoso Mantke, Oliver, et al.
Publicado: (2018)

Ensuring high standards for the delivery of NIPT world‐wide: Development of an international external quality assessment scheme
por: Deans, Zandra C., et al.
Publicado: (2019)

Estimating the parasitaemia of Plasmodium falciparum: experience from a national EQA scheme
por: Manser, Monika, et al.
Publicado: (2013)

Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
por: Moerman, Alena, et al.
Publicado: (2022)

Demystifying EQA statistics and reports
por: Coucke, Wim, et al.
Publicado: (2017)

Bioinformatics: From NGS Data to Biological Complexity in Variant Detection and Oncological Clinical Practice
por: Dotolo, Serena, et al.
Publicado: (2022)

EQA/PT scheme to improve the equivalence of enzymatic results between mutual recognition laboratories in Beijing
por: Tong, Qing, et al.
Publicado: (2021)

Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021)

FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention
por: De Luca, Antonella, et al.
Publicado: (2020)

Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
por: Roma, Cristin, et al.
Publicado: (2022)

District level external quality assurance (EQA) of malaria microscopy in Pakistan: pilot implementation and feasibility
por: Khan, Muhammad Amir, et al.
Publicado: (2011)

Improvement of the quality of BRAF testing in melanomas with nationwide external quality assessment, for the BRAF EQA group
por: Emile, Jean-François, et al.
Publicado: (2013)

External quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in primary laboratories in Germany
por: Selb, Regina, et al.
Publicado: (2020)

Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
por: Esposito Abate, Riziero, et al.
Publicado: (2020)

Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma
por: Rachiglio, Anna Maria, et al.
Publicado: (2016)

Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)—Pitfalls of Routine Application
por: Kittel, Maximilian, et al.
Publicado: (2022)

The WHO AFRO external quality assessment programme (EQAP): Linking laboratory networks through EQA programmes
por: Boeras, Debrah I., et al.
Publicado: (2016)

Inter-Laboratory Comparisons and EQA in the Mediterranean Area
por: Haliassos, Alexander
Publicado: (2018)

The challenge of producing an EQA for the COVID-19 pandemic
por: Badrick, Tony, et al.
Publicado: (2020)

A multiple network-based bioinformatics pipeline for the study of molecular mechanisms in oncological diseases for personalized medicine
por: Dotolo, Serena, et al.
Publicado: (2021)

Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
por: Ast, Volker, et al.
Publicado: (2021)

Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib
por: Esposito Abate, Riziero, et al.
Publicado: (2019)

Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
por: Keppens, Cleo, et al.
Publicado: (2021)

Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016
por: van Krieken, Han, et al.
Publicado: (2016)

First Results of an External Quality Assessment (EQA) Scheme for Molecular, Serological and Antigenic Diagnostic Test for SARS-CoV-2 Detection in Lombardy Region (Northern Italy), 2020–2022
por: Pasotti, Fabio, et al.
Publicado: (2022)

Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing
por: Jurmeister, Philipp, et al.
Publicado: (2021)

How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation
por: Richman, Susan D, et al.
Publicado: (2017)

The role of EQA in harmonization in laboratory medicine – a global effort
por: Jones, Graham R.D.
Publicado: (2017)

Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data
por: Cole, Michelle J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2ic420eppshs282e4l4iam9avm